Chenyu Lin

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia”.

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025017526

N/A

0.267DataRank · unranked

3 citations

Chenyu Lin, David Nemirovsky, Sean Devlin, Kai Rejeski, Kevin J. Curran +43 more

Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.09.018

N/A

0DataRank · unranked

12 citations

Gautam Sajeev, Patrick J. Stiff, Claudio G. Brunstein, Corey Cutler, Guillermo Sanz +14 more

Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond

International Journal of Molecular Sciences(2022)10.3390/ijms24010204

N/A

0DataRank · unranked

7 citations

Mitchell E. Horwitz, Lindsay Rein, Chenyu Lin

Frequency of practice-changing findings identified by comprehensive genomic profiling in non-myeloid hematologic malignancies.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3060

N/A

0DataRank · unranked

0 citations

Chenyu Lin, Michelle Green, Bennett Adam Caughey, Michael Datto, John H. Strickler +2 more

Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma

Cancer Investigation(2023)10.1080/07357907.2022.2162073

N/A

0DataRank · unranked

1 citations

Ahmed M. Galal, David A. Rizzieri, Sant P. Chawla, Seung‐Tae Lee, Angela Georgy +4 more

Telemedicine-supervised cancer therapy for patients with an aggressive lymphoma and metastatic lung cancer in the U.S. Veterans Affairs National TeleOncology Service.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1602

N/A

0DataRank · unranked

1 citations

Katherine I. Zhou, Zachary Burningham, Kerry Rowe, Tori Anglin-Foote, Mark Maddox +6 more

Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis

Blood Advances(2024)10.1182/bloodadvances.2024013688

N/A

0DataRank · unranked

40 citations

Qiuhong Zhao, Marcus Geer, Chenyu Lin, James Westholder, Joeseph Maakaron +12 more

Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction

British Journal of Haematology(2024)10.1111/bjh.19737

N/A

0DataRank · unranked

0 citations

Clare Anderson, Micaela R. Scobie, Thomas D. Rodgers, Michael J. Kelley, Daphne R. Friedman +1 more

Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice

Hematology Reports(2024)10.3390/hematolrep16040059

N/A

0DataRank · unranked

0 citations

Katherine I. Zhou, Michelle Green, Bennett Adam Caughey, John H. Strickler, Michael Datto +2 more

Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.005

N/A

0DataRank · unranked

49 citations

Andrew A. Davis, Maurizio Polano, Qiang Zhang, Ami N. Shah, Chenyu Lin +9 more

Outcomes of myeloablative allogeneic hematopoietic cell transplantation with omidubicel vs alternative donor sources

Blood Neoplasia(2025)10.1016/j.bneo.2025.100104

N/A

0DataRank · unranked

0 citations

Smitha Sivaraman, Gautam Sajeev, Yan Song, Chunyi Xu, Chujun He +8 more